Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

BBC: 'Jaw-dropping' MHRA report includes 50 pharmacies under scrutiny

Fifty pharmacies have so far been implicated in an investigation into the diversion of prescription-only medicines (POMs) onto the criminal market, the BBC has claimed.

BBC Radio 4’s File on 4 programme – which aired last night – aimed to investigate the “extensive network of criminality involving businesses such as wholesale dealers and registered pharmacies” diverting POMs to be sold illegally online, which the UK’s medicines watchdog revealed earlier in the day (January 30).

The Medicines and Healthcare products Regulatory Agency (MHRA) said that its latest crackdown – which leads on from its 2016 investigation into the “significant diversion of benzodiazepines and other hypnotics/anxiolytics” onto the black market – involves a “small number of registered pharmacies”.

The BBC – which claimed to have seen a full copy of the MHRA’s intelligence report – said 50 pharmacies have so far been implicated in the investigations.

“Frankly, it’s jaw-dropping,” presenter Allan Urry said in the programme.

“There are around 20 investigations covering the UK, 71 people are potentially involved – 18 pharmacists, 11 doctors, 62 companies, and 50 pharmacies,” he claimed.

“According to the MHRA intelligence report, pharmacists are involved in 90% of the cases they are investigating,” Mr Urry alleged.

At time of going to press, the MHRA had not responded to C+D's request to confirm these figures.

“White collar insiders”

According to the BBC, the report references “a solid interface” between “white collar” workers operating “inside the regulated supply chain”, and “organised criminal groups”.

The “epicentre” of the criminal network stems from “the north-west of England – running through the [Staffordshire] potteries, the Midlands and onto London”, the BBC added.

Investigations so far have focused on diazepam, nitrazepam, temazepam, zopiclone, zolpidem, pregabalin, gabapentin and tramadol in “all strengths, in tablet form”, the MHRA said yesterday.

In the radio programme, MHRA head of enforcement Alastair Jeffrey said the agency has also investigated three websites where POMs were being sold illegally.

“On these three websites, up to 100 transactions per day [were] being made for these types of medicines. We're looking at something in the region of £55 million having gone through these three websites over a 12-15 month period,” he said in the programme.

“That is probably a conservative estimate.”

The MHRA would not reveal to C+D the names of the pharmacies, wholesalers and websites involved in the ongoing investigations.

The General Pharmaceutical Council (GPhC) said yesterday that five pharmacists have been suspended under “interim orders” while the investigation is ongoing.

The regulator told C+D today that the five suspensions include the two pharmacists in Yorkshire who were arrested in relation to the purchase of more than 200,000 packs of benzodiazepines “and other powerful drugs”, as part of the MHRA’s 2016 investigation.

Catch up with last night's File on 4 episode, ‘A Deadly Prescription’, on BBCiPlayer here

Are you aware of patients buying POMs illegally?

Related Content

Topics



Pharmacist Managers - Recruiting Now !
East London, Essex and Luton
£40,000 - £50,000 per year

Apply Now
UsernamePublicRestriction

Register

CD009150

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel